<?xml version="1.0" encoding="UTF-8"?>
<ref id="B47-vaccines-08-00307">
 <label>47.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Frei</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Wirchnianski</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Govero</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Vergnolle</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Dowd</surname>
    <given-names>K.A.</given-names>
   </name>
   <name>
    <surname>Pierson</surname>
    <given-names>T.C.</given-names>
   </name>
   <name>
    <surname>Kielian</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Girvin</surname>
    <given-names>M.E.</given-names>
   </name>
   <name>
    <surname>Diamond</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Lai</surname>
    <given-names>J.R.</given-names>
   </name>
  </person-group>
  <article-title>Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice</article-title>
  <source>J. Virol.</source>
  <year>2018</year>
  <volume>92</volume>
  <pub-id pub-id-type="doi">10.1128/JVI.01023-18</pub-id>
 </element-citation>
</ref>
